In a filing, Tscan Therapeutics Inc revealed its Director BARBERICH TIMOTHY J acquired Company’s shares for reported $1575.0 on Dec 19 ’23. In the deal valued at $4.97 per share,317 shares were bought. As a result of this transaction, BARBERICH TIMOTHY J now holds 67,027 shares worth roughly $0.54 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, BARBERICH TIMOTHY J bought 28,830 shares, generating $140,881 in total proceeds. Upon buying the shares at $4.89, the Director now owns 66,710 shares.
Before that, Klencke Barbara bought 5,000 shares. Tscan Therapeutics Inc shares valued at $25,400 were divested by the Director at a price of $5.08 per share. As a result of the transaction, Klencke Barbara now holds 30,000 shares, worth roughly $0.24 million.
Wedbush initiated its Tscan Therapeutics Inc [TCRX] rating to an Outperform in a research note published on June 22, 2023; the price target was $8.
Price Performance Review of TCRX
On Friday, Tscan Therapeutics Inc [NASDAQ:TCRX] saw its stock jump 14.41% to $8.02. Over the last five days, the stock has gained 12.64%. Tscan Therapeutics Inc shares have risen nearly 37.56% since the year began. Nevertheless, the stocks have risen 213.28% over the past one year. While a 52-week high of $7.87 was reached on 03/22/24, a 52-week low of $1.62 was recorded on 01/25/24. SMA at 50 days reached $6.22, while 200 days put it at $4.17. A total of 0.53 million shares were traded, compared to the trading of 86900.0 shares in the previous session.
Levels Of Support And Resistance For TCRX Stock
The 24-hour chart illustrates a support level at 7.44, which if violated will result in even more drops to 6.86. On the upside, there is a resistance level at 8.33. A further resistance level may holdings at 8.64. The Relative Strength Index (RSI) on the 14-day chart is 70.33, which indicates overbought technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.37, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 2.33%. Stochastics %K at 68.90% indicates the stock is a holding.
How much short interest is there in Tscan Therapeutics Inc?
A steep rise in short interest was recorded in Tscan Therapeutics Inc stocks on Feb 29, 2024, dropping by 55860.0 shares to a total of 0.19 million shares. Yahoo Finance data shows the prior-month short interest on Jan 31, 2024 was 0.24 million shares. There was a decline of -29.76%, which implies that there is a negative sentiment for the stock. In spite of short shares comprising just 0.49% of the overall stock float, the days-to-cover ratio (short ratio) fell to 1.08.
